高级检索
当前位置: 首页 > 详情页

Integrated image-based deep learning and language models for primary diabetes care

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE ◇ 自然指数

作者:
机构: [1]Shanghai Sixth Peoples Hosp Affiliated Shanghai Ji, Shanghai Diabet Inst,Dept Comp Sci & Engn,Sch Elec, Shanghai Key Lab Diabet,Dept Endocrinol & Metab, Shanghai Clin Ctr Diabet,Shanghai Belt & Int Joint, Shanghai, Peoples R China [2]Shanghai Jiao Tong Univ, MoE Key Lab AI, Sch Elect Informat & Elect Engn, Shanghai, Peoples R China [3]Huadong Sanat, Dept Ophthalmol, Wuxi, Peoples R China [4]Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Peoples R China [5]Sun Yat Sen Univ, Guangdong Prov Key Lab Ophthalmol & Visual Sci, Guangdong Prov Clin Res Ctr Ocular Dis, State Key Lab Ophthalmol,Zhongshan Ophthalm Ctr, Guangzhou, Peoples R China [6]Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia [7]Singapore Gen Hosp, Dept Renal Med, Singhlth Duke Acad Med Ctr, Singapore, Singapore [8]Rangsit Univ, Rajavithi Hosp, Fac Med, Dept Ophthalmol,Coll Med, Bangkok, Thailand [9]Sankara Nethralaya, Med Res Fdn, Shri Bhagwan Mahavir Vitreoretinal Serv, Chennai, India [10]Duke Sch Med, Dept Med, Dept Populat Hlth Sci, Div Endocrinol Metab & Nutr, Durham, NC USA [11]Johns Hopkins Univ, Sch Med, Div Endocrinol Diabet & Metab, Dept Med, Baltimore, MD USA [12]Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Peoples R China [13]Chinese Univ Hong Kong, Hong Kong Inst Diabet & Obes, Hong Kong, Peoples R China [14]Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong Special Adm Reg, Hong Kong, Peoples R China [15]Asia Diabet Fdn, Hong Kong, Peoples R China [16]Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Ophthalmol, Shanghai, Peoples R China [17]Singapore Eye Res Inst, Singapore Natl Eye Ctr, Singapore, Singapore [18]Shanghai Sixth Peoples Hosp Affiliated Shanghai Ji, Dept Otorhinolaryngol, Sch Med, Shanghai, Peoples R China [19]Capital Med Univ, Beijing Inst Ophthalmol, Beijing Tongren Hosp, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China [20]Peoples Hosp Sixian Cty, Chizhou, Anhui, Peoples R China [21]Shanghai Eighth Peoples Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China [22]Univ Ferhat Abbas Setif, Dept Internal Med, Setif, Algeria [23]Tashkent Adv Training Inst Doctors, Ophthalmology Department, Tashkent, Uzbekistan [24]Charity Union Persons Disabilities & People Diabet, Tashkent, Uzbekistan [25]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Geriatr, Wuhan, Peoples R China [26]Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Ophthalmol, Beijing, Peoples R China [27]Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Epidemiol & Publ Hlth,Natl Univ Polyclin, Singapore, Singapore [28]Univ Malaya, Fac Med, Dept Primary Care Med, Kuala Lumpur, Malaysia [29]Univ Malaya, Med Ctr, Dept Med, Kuala Lumpur, Malaysia [30]Singapore Gen Hosp, Dept Endocrinol, Singapore, Singapore [31]Natl Univ Hlth Syst, Natl Univ Hosp, Univ Med Cluster, Div Endocrinol, Singapore, Singapore [32]Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore [33]Huadong Sanat, Dept Internal Med, Wuxi, Jiangsu, Peoples R China [34]Tsinghua Univ, Inst AI Ind Res, Beijing, Peoples R China [35]Shanghai Jiao Tong Univ, Dept Automat, Shanghai 200240, Peoples R China [36]Shanghai Jiao Tong Univ, Key Lab Syst Control & Informat Proc, Minist Educ China, Shanghai, Peoples R China [37]Univ London, Int Ctr Eye Hlth, London Sch Hyg & Trop Med, London, England [38]Austin Hlth, Dept Endocrinol, Melbourne, Vic, Australia [39]Univ Melbourne, Austin Hlth, Dept Med, Melbourne, Vic, Australia [40]Univ Melbourne, Australian Ctr Accelerating Diabet Innovat, Parkville, Vic, Australia [41]Baker Heart & Diabet Inst, Melbourne, Vic, Australia [42]Univ Sydney, NHMRC, Clin Trials Ctr, Sydney, NSW, Australia [43]Moorfields Eye Hosp, NIHR Moorfields Biomed Res Ctr, London, England [44]Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain [45]Autonomous Univ Barcelona, Vall dHebron Res Inst, Diabet & Metab Res Unit, Barcelona, Spain [46]UCL, Inst Ophthalmol, London EC1V 9EL, England [47]Natl Univ Singapore, Ctr Innovat & Precis Eye Hlth, Yong Loo Lin Sch Med, Singapore, Singapore [48]Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore, Singapore [49]Duke NUS Med Sch, Ophthalmol & Visual Sci Acad Clin Program, Singapore, Singapore [50]Tsinghua Univ, Sch Clin Med, Tsinghua Med, Beijing, Peoples R China [51]Beijing Tsinghua Changgung Hosp, Beijing, Peoples R China [52]Zhongshan Ophthalm Ctr, Guangzhou, Peoples R China
出处:
ISSN:

摘要:
Primary diabetes care and diabetic retinopathy (DR) screening persist as major public health challenges due to a shortage of trained primary care physicians (PCPs), particularly in low-resource settings. Here, to bridge the gaps, we developed an integrated image-language system (DeepDR-LLM), combining a large language model (LLM module) and image-based deep learning (DeepDR-Transformer), to provide individualized diabetes management recommendations to PCPs. In a retrospective evaluation, the LLM module demonstrated comparable performance to PCPs and endocrinology residents when tested in English and outperformed PCPs and had comparable performance to endocrinology residents in Chinese. For identifying referable DR, the average PCP's accuracy was 81.0% unassisted and 92.3% assisted by DeepDR-Transformer. Furthermore, we performed a single-center real-world prospective study, deploying DeepDR-LLM. We compared diabetes management adherence of patients under the unassisted PCP arm (n = 397) with those under the PCP+DeepDR-LLM arm (n = 372). Patients with newly diagnosed diabetes in the PCP+DeepDR-LLM arm showed better self-management behaviors throughout follow-up (P < 0.05). For patients with referral DR, those in the PCP+DeepDR-LLM arm were more likely to adhere to DR referrals (P < 0.01). Additionally, DeepDR-LLM deployment improved the quality and empathy level of management recommendations. Given its multifaceted performance, DeepDR-LLM holds promise as a digital solution for enhancing primary diabetes care and DR screening.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 1 区 医学
小类 | 1 区 生化与分子生物学 1 区 细胞生物学 1 区 医学:研究与实验
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 生化与分子生物学 1 区 细胞生物学 1 区 医学:研究与实验
JCR分区:
出版当年[2022]版:
Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Q1 CELL BIOLOGY Q1 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Q1 CELL BIOLOGY Q1 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [1]Shanghai Sixth Peoples Hosp Affiliated Shanghai Ji, Shanghai Diabet Inst,Dept Comp Sci & Engn,Sch Elec, Shanghai Key Lab Diabet,Dept Endocrinol & Metab, Shanghai Clin Ctr Diabet,Shanghai Belt & Int Joint, Shanghai, Peoples R China [2]Shanghai Jiao Tong Univ, MoE Key Lab AI, Sch Elect Informat & Elect Engn, Shanghai, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Shanghai Sixth Peoples Hosp Affiliated Shanghai Ji, Shanghai Diabet Inst,Dept Comp Sci & Engn,Sch Elec, Shanghai Key Lab Diabet,Dept Endocrinol & Metab, Shanghai Clin Ctr Diabet,Shanghai Belt & Int Joint, Shanghai, Peoples R China [2]Shanghai Jiao Tong Univ, MoE Key Lab AI, Sch Elect Informat & Elect Engn, Shanghai, Peoples R China [17]Singapore Eye Res Inst, Singapore Natl Eye Ctr, Singapore, Singapore [47]Natl Univ Singapore, Ctr Innovat & Precis Eye Hlth, Yong Loo Lin Sch Med, Singapore, Singapore [48]Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore, Singapore [49]Duke NUS Med Sch, Ophthalmol & Visual Sci Acad Clin Program, Singapore, Singapore [50]Tsinghua Univ, Sch Clin Med, Tsinghua Med, Beijing, Peoples R China [51]Beijing Tsinghua Changgung Hosp, Beijing, Peoples R China [52]Zhongshan Ophthalm Ctr, Guangzhou, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:25477 今日访问量:0 总访问量:1499 更新日期:2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)